Naprod Life Sciences Private Limited — Doxorubicin Exporter Profile
Indian Pharmaceutical Exporter · #10 for Doxorubicin · $1.1M export value · DGFT Verified
Naprod Life Sciences Private Limited is the #10 Indian exporter of Doxorubicin with $1.1M in export value and 85 verified shipments. Naprod Life Sciences Private Limited holds a 1.6% market share in Doxorubicin exports across 22 countries. The company exports 23 pharmaceutical products worth $18.7M across 4 therapeutic categories.
Naprod Life Sciences Private Limited — Doxorubicin Export Profile: Buyers & Destinations
Where Does Naprod Life Sciences Private Limited Export Doxorubicin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MOROCCO | $268.0K | 15 | 26.7% |
| PAKISTAN | $201.2K | 8 | 20.1% |
| SOUTH AFRICA | $140.1K | 11 | 14.0% |
| PERU | $108.8K | 5 | 10.9% |
| SRI LANKA | $50.0K | 1 | 5.0% |
| ZIMBABWE | $29.0K | 6 | 2.9% |
| CHILE | $26.9K | 2 | 2.7% |
| ECUADOR | $26.8K | 1 | 2.7% |
| TRINIDAD & TOBAGO | $25.1K | 4 | 2.5% |
| KENYA | $19.0K | 2 | 1.9% |
Naprod Life Sciences Private Limited exports Doxorubicin to 24 countries. The largest destination is MOROCCO accounting for 26.7% of Naprod Life Sciences Private Limited's Doxorubicin shipments, followed by PAKISTAN (20.1%) and SOUTH AFRICA (14.0%). These destinations reflect Naprod Life Sciences Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Doxorubicin from Naprod Life Sciences Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| HABIB BANK LIMITED | PAKISTAN | $166.2K | 7 |
| TO ATTIJARIWAFA BANK | MOROCCO | $94.5K | 5 |
| SEVEN PHARMA S A C | PERU | $55.8K | 2 |
| EQUITY PHARMACEUTICALS (PTY) LTD | SOUTH AFRICA | $55.0K | 2 |
| STATE PHARMACEUTICALS CORPORATION O | SRI LANKA | $50.0K | 1 |
| LABORATOIRE PHARMACEUTIQUE NOVAPHAR | MOROCCO | $50.0K | 1 |
| ATTIJARIWAFA BANK | MOROCCO | $50.0K | 1 |
| SEVEN PHARMA SACAV MICHAEL FARADAY | PERU | $48.1K | 2 |
| OETHMAAN BIOSIMS (PTY) LTD | SOUTH AFRICA | $35.5K | 4 |
| OETHMAAN BIOSIMS (PTY) LIMITED | SOUTH AFRICA | $35.3K | 2 |
Naprod Life Sciences Private Limited supplies Doxorubicin to 48 buyers globally. The largest buyer is HABIB BANK LIMITED (PAKISTAN), followed by TO ATTIJARIWAFA BANK (MOROCCO) and SEVEN PHARMA S A C (PERU). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Doxorubicin Export Value and How Much Does Naprod Life Sciences Private Limited Contribute?
India exported $21.8M worth of Doxorubicin through 3,492 shipments from 310 suppliers to 136 countries, serving 899 buyers globally. Naprod Life Sciences Private Limited contributes $1.1M to this total, accounting for 1.6% of India's Doxorubicin exports. Naprod Life Sciences Private Limited ships Doxorubicin to 24 countries through 48 buyers.
What Is the Average Shipment Value for Naprod Life Sciences Private Limited's Doxorubicin Exports?
Naprod Life Sciences Private Limited's average Doxorubicin shipment value is $12.4K per consignment, based on 85 shipments totaling $1.1M. The largest destination is MOROCCO (26.7% of Naprod Life Sciences Private Limited's Doxorubicin exports).
How Does Naprod Life Sciences Private Limited Compare to Other Indian Doxorubicin Exporters?
Naprod Life Sciences Private Limited ranks #10 among 310 Indian Doxorubicin exporters with a 1.6% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($7.5M), FRESENIUS KABI ONCOLOGY LIMITED ($3.1M), DR.REDDY'S LABORATORIES LTD ($2.5M). Naprod Life Sciences Private Limited processed 85 shipments to 22 destination countries.
What Doxorubicin Formulations Does Naprod Life Sciences Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DOXORUBICIN NAPROD (DOXORUBICIN HYDROCHL | $80.3K | 3 |
| Doxorubicin Naprod Doxorubicin Hydrochloride for Injection BP 50mg | $62.5K | 3 |
| DOXRED 50 LYOPHILISED POWDER DOXORUBICINHYDROCHLORIDE FOR INJECTION BP 50MG | $55.0K | 2 |
| Doxorubicin Hydrochloride For InjectionBP 50mg | $53.1K | 2 |
| DOXORUBICIN HYDROCHLORIDE FOR INJECTIONBP 50MG 21740 VIALS | $50.0K | 1 |
| DOXORUBICIN NAPROD (DOXORUBICIN HYDROCHLORIDE FOR INJECTION BP 50MG) (12180 VIALS) | $50.0K | 1 |
| NAPRODOX 50 (DOXORUBICIN HYDROCHLORIDE F | $45.4K | 2 |
| Naprodox 50Doxorubicin Hydrochloride ForInjection BP 50mg | $38.4K | 2 |
| NAPRODOX 50 (DOXORUBICIN HYDROCHLORIDE FOR INJECTION BP 50MG) (10000 VIALS) | $38.2K | 1 |
| NAPRODOX 50 DOXORUBICIN HYDROCHLORIDE FOR INJECTION BP 50MG 10100 VIALS | $37.4K | 1 |
Naprod Life Sciences Private Limited exports 56 distinct Doxorubicin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DOXORUBICIN NAPROD (DOXORUBICIN HYDROCHL with 3 shipments worth $80.3K.
Regulatory Requirements: Exporting Doxorubicin to Key Markets
What Naprod Life Sciences Private Limited must comply with to export Doxorubicin to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Naprod Life Sciences Private Limited Compare to Nearest Doxorubicin Exporters?
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | EUGIA PHARMA SPECIALITIES LIMITED | $1.4M | 98 | 1 | $14.7K |
| 9 | VENUS REMEDIES LIMITED | $1.1M | 100 | 15 | $11.0K |
| 10 | NAPROD LIFE SCIENCES PRIVATE LIMITED ★ | $1.1M | 85 | 22 | $12.4K |
| 5 | DR REDDYS LABORATORIES LIMITED | $550.0K | 11 | 2 | $50.0K |
| 11 | GETWELL PHARMA INDIA PRIVATE LIMITED | $525.9K | 81 | 11 | $6.5K |
Naprod Life Sciences Private Limited ranks #10 among 310 Indian Doxorubicin exporters. Average shipment value of $12.4K compared to the market average of $70.4K. The closest competitors by value are EUGIA PHARMA SPECIALITIES LIMITED and VENUS REMEDIES LIMITED.
Which Indian Ports Ship Doxorubicin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 639 | 18.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 577 | 16.5% |
| DELHI AIR CARGO ACC (INDEL4) | 464 | 13.3% |
| DELHI AIR | 399 | 11.4% |
| Bombay Air | 188 | 5.4% |
| AHEMDABAD AIR | 150 | 4.3% |
| AHEMDABAD AIR ACC (INAMD4) | 120 | 3.4% |
| Delhi Air | 85 | 2.4% |
What Other Oncology Products Does Naprod Life Sciences Private Limited Export?
Naprod Life Sciences Private Limited also exports these oncology products. Each links to the detailed product page.
About Naprod Life Sciences Private Limited
Naprod Life Sciences Private Limited exports 23 products worth $18.7M. Beyond Doxorubicin, top products include Carboplatin, Fluorouracil, Oxaliplatin, Methotrexate, Gemcitabine. View the complete Naprod Life Sciences Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Doxorubicin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Doxorubicin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Naprod Life Sciences Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 86 individual customs records matching Naprod Life Sciences Private Limited exporting Doxorubicin, covering 56 formulations to 24 countries via 48 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 136+ countries, 899+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Doxorubicin Export Data from Naprod Life Sciences Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Naprod Life Sciences Private Limited's Doxorubicin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Naprod Life Sciences Private Limited
Full Company Profile →
23 products · $18.7M total trade · 4 categories
Doxorubicin Stats
Company Overview
Top Products by Naprod Life Sciences Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Naprod Life Sciences Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Doxorubicin. For current shipment-level data, contact TransData Nexus.